International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8253022
Original Article
Visual Outcome in Axial Myopes Following Cataract Surgery
 ,
 ,
Published
Aug. 16, 2023
Abstract

Objective: To evaluate visual outcome following cataract surgery in axial myopes.

Methodology: In this prospective study 49 patients with axial myopia i.e, axial length >25mm were included. 49 eyes underwent lens extraction with Posterior chamber intraocular lens implantion (Small incision cataract surgery and phacoemulsification). Complete ophthalmic examination with slit lamp examination fundus examination were performed preoperatively. B scan was done in patients whose fundus had no glow to rule out posterior staphyloma.  Biometry calculation was performed using SRK/T formula. Postoperatively visual outcome in terms of snellen’s acuity was performed.

Results: The mean age of patient operated was about 52. The study included 9 patients with nuclear cataract, 9 with mature cataracts, 10 with brown cataract and 21 with posterior sub capsular cataract which was common type of cataract. 71% subjects had 6/6 vision post cataract surgery. Intraoperatively no significant complications were noted.

Conclusion: Satisfactory snellen’s visual acuity was achieved in in patients with axial myopes following cataract surgery. And also both visual and refractive problems in patients with cataracts and high myopia is solved.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
301 Views
294 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved